Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Start Up Company Licenses University Polymer Research

Spherulites, polymer crystals (National Science Foundation)

A new start up company has licensed advanced polymers research at Case Western Reserve University in Cleveland, Ohio, aiming to commercialize polymer technology. PolymerPlus LLC, in nearby Valley View, plans to work with some of the intellectual property developed at the university’s Center for Layered Polymeric Systems . . . → Read More: Start Up Company Licenses University Polymer Research

Process Developed for High-Quality Gluten-Free Bread

(Agricultural Research Service/USDA)

Chemists with the USDA’s Agricultural Research Service (ARS) in Manhattan, Kansas have developed a process for high-quality, gluten-free bread. According to National Institutes of Health, some two million Americans suffer from celiac disease, which makes them unable to digest gluten, a protein in flour from grains such as wheat, barley . . . → Read More: Process Developed for High-Quality Gluten-Free Bread

NFL Grant Funds Bioengineered Spinal Disc Research

(NIH)

Researchers from Cornell University in Ithaca, New York and Weill Cornell Medical College in New York City have received a $100,000 grant from NFL Charities to research tissue engineering for spinal injuries. NFL Charities is the charitable foundation of the National Football League owners.

The research aims to create a living, bioengineered . . . → Read More: NFL Grant Funds Bioengineered Spinal Disc Research

Investor Company to Offer Cancer Therapy Development Funding

Mentor Capital Inc. in San Diego, California plans to extend its funding beyond cancer immunotherapy — its current specialty — to other leading cancer solutions. Its objective is to provide investments that fill the gap for therapies between initial lab development and their acquisition by major pharmaceutical companies. This middle stage is often called “The . . . → Read More: Investor Company to Offer Cancer Therapy Development Funding

Doctoral Candidate Develops Stress-Reducing Pen

(Delft University of Technology)

Researcher Miguel Bruns Alonso, a Ph.D. candidate at Delft University of Technology (TU Delft) in the Netherlands, has developed a pen that measures the stress levels of the person using it, and can help to reduce that stress. Bruns is expected to receive his doctoral degree in industrial design . . . → Read More: Doctoral Candidate Develops Stress-Reducing Pen

VCs Expect More Deals in 2011, but Not for Science

(Investor.gov)

A survey of U.S. venture capital (VC) investors shows expectations of more investments for entrepreneurs in 2011 across all company stages from initial seed funding to later stage rounds. More VCs expect investments to increase in technology-related companies, however, rather than those based on scientific discoveries. The survey of 330 VC investors . . . → Read More: VCs Expect More Deals in 2011, but Not for Science

Taiwan Chip Maker to Raise R&D Nearly 40%

The Taipei Times reports today that Taiwan Semiconductor Manufacturing Company (TSMC) in Hsinchu, Taiwan plans to raise its research and development spending by 39 percent next year to NT$50 billion (US$1.63 billion), due to more aggressive competition in TSMC’s market.

TSMC is the world’s largest contract chip manufacturer. At present, the company does not directly . . . → Read More: Taiwan Chip Maker to Raise R&D Nearly 40%

Nanosatellites Launched in SpaceX Falcon Vehicle

Liftoff of Falcon spacecraft (SpaceX)

Among the payloads in the commercial Space Exploration (SpaceX) Technologies Inc., Falcon 9 vehicle, launched into low-earth orbit on 8 December were two two small satellites, called nanosatellites, built by the U.S. Naval Research Lab. The lab, part of the Department of Defense, says the launch of these . . . → Read More: Nanosatellites Launched in SpaceX Falcon Vehicle

Light posting for the next few days

We’ll be taking a short break beginning tomorrow through Monday, which will cut down on the number of items we post during that time. We’ll get back to our regular volume next Tuesday.

* * *

Biotech Inks Three New Drug Discovery Deals

Adimab Inc., a biotechnology company in Lebanon, New Hampshire today announced three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. The company offers a technology platform for the discovery of human antibodies.

For Eli Lilly, Adimab will use its discovery platform to identify fully human antibodies against two targets selected by . . . → Read More: Biotech Inks Three New Drug Discovery Deals